Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate and nebivolol hydrochloride, the active ingredients in Nesyrgy, are a calcium channel blocker and a beta‑blocker presented as a tablet for oral use. The combination is indicated for the management of hypertension in adult patients.

GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All batches are manufactured under EU GMP standards and undergo rigorous quality testing before release. The company provides regulatory support and reliable logistics to ensure timely delivery to global markets.

Nesyrgy is used to treat hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: reduces systolic and diastolic blood pressure by vasodilation and decreased cardiac output. - Essential hypertension: provides long‑term blood pressure control in patients with primary hypertension. - Isolated systolic hypertension: helps lower elevated systolic pressure in older adults.

Like all antihypertensive agents, Nesyrgy may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Peripheral edema: swelling of the ankles or feet. - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Dizziness: light‑headedness, especially on standing.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Bradycardia: abnormally slow heart rate. - Angioedema: swelling of face, lips, tongue or airway.

Before prescribing Nesyrgy, clinicians should evaluate patient history and monitor specific parameters to ensure safe use. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Cardiac function assessment: evaluate heart rate and conduction, especially in patients with bradycardia. - Hepatic impairment: use caution and consider dose adjustment in moderate to severe liver disease. - Concomitant CYP3A4 inhibitors: review medications that may increase amlodipine levels. - Pregnancy and lactation: avoid use unless benefits outweigh risks, as safety data are limited. - Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Nesyrgy can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise amlodipine concentrations and increase risk of hypotension. - Combined use with other antihypertensives (e.g., ACE inhibitors, diuretics) without dose adjustment: can cause excessive blood pressure lowering. - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): additive cardiac depression and bradycardia.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase nebivolol levels. - NSAIDs (e.g., ibuprofen, naproxen): can reduce antihypertensive effect. - Digoxin: may require monitoring of plasma levels due to potential changes in renal clearance.